3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other
8
Gastrointestinal
6
Endocrine
4
Breast
4
Other hematologic neoplasm
2
Lymphoid
2
Dermatologic
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
885
Precursor Cell Lymphoblastic Leukemia-Lymphoma
511
Hematologic Neoplasms
464
Leukemia, Lymphocytic, Chronic, B-Cell
392
Leukemia
336
Myelodysplastic Syndromes
330
Lymphoma
207
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
146
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
142
Recurrence
138
Neoplasms
135
Leukemia, Myelomonocytic, Chronic
112
Burkitt Lymphoma
93
Lymphoma, Mantle-Cell
92
Lymphoma, Follicular
92
Lymphoma, Large B-Cell, Diffuse
91
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Leukemia, Biphenotypic, Acute
81
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
54
Leukemia, B-Cell
52
Anemia, Refractory, with Excess of Blasts
46
Leukemia, Myeloid, Chronic-Phase
41
Hematologic Diseases
37
Lymphoma, T-Cell
33
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT04952766
2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4
Completed
196 enrolled
NCT07086989
2025-08-08
CR3C
Semmelweis University
Recruiting
300 enrolled